Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

The NHS has warned that certain people should contact their GP before taking a common medication. The drug, which is only ...

The gut bacteria B. adolescentis eased lung scarring in a pulmonary fibrosis mouse model, showing potential as a preventive ...

A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...

Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...

'Robbing them': Treasury slams states over Trump tax cuts Experts warn the internet will go down in a big way — and you'd ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...